Glaxosmithkline

Indian generic drugmakers may face supply shortages from China if coronavirus drags on: Report

An important supplier of generic drugs to the world, Indian companies procure almost 70 percent of the active pharmaceutical ingredients (APIs) for their medicines from China.

Researchers find a compound that can halt growth of parasite that causes malaria

Apparently, a compound developed by GlaxoSmithKline can eliminate the mosquito-borne parasite in all the stages of its lifecycle.

CCI approves GlaxoSmithKline, Pfizer consumer healthcare joint venture

The Competition Commission on Friday said it has approved the formation of a joint venture for consumer healthcare products by pharmaceutical giants GlaxoSmithKline (GSK) and Pfizer

Pfizer to shut down two plants in India citing unviability; decision leaves about 1,700 employees in lurch

Pfizer will soon shut down its plants in Aurangabad, Maharashtra and Irungattukottai (IKKT) near Chennai in Tamil Nadu citing lack of viability.

GSK and Pfizer to combine consumer health businesses; British drugmaker plans to split into two businesses

GSK said the deal laid the foundation for the creation of two new UK-based global companies focused on pharmaceuticals/vaccines and consumer healthcare

Unilever CEO Paul Polman steps down after headquarters move fiasco, replaced by insider Alan Jope

A UK investor revolt forced Polman and the Unilever board to scrap a plan in October to move the headquarters of the dual-listed company to the Netherlands

GSK Consumer Healthcare says it is considering potential transaction of nutrition business; Unilever confirms development

Hindustan Unilever, the Indian arm of Unilever, confirmed that the company was in the race to acquire GlaxoSmithKline Plc's consumer healthcare nutrition products

Unilever emerges as leading bidder in tight contest for GlaxoSmithKline's Horlicks nutrition business

GSK’s assets, which include the popular malt-based drinks Horlicks and Boost, is likely to fetch less than $4 billion, said people close the deal

Coca-Cola in race to buy Horlicks from GlaxoSmithKline, value of transaction could be around $3.9 billion

Besides Coca-Cola, several global FMCG makers as Nestle, Kraft Heinz are in the race to acquire Horlicks from GSK

Glenmark Pharma pushes first generic product in Europe with asthma drug in Denmark

Glenmark said it has already received National Marketing Authorizations for the product in Sweden, Finland, Norway and Iceland.